Development and Differentiation of Midbrain Dopaminergic Neuron: From Bench to Bedside
Parkinson’s Disease (PD) is a neurodegenerative disorder affecting the motor system. It is primarily due to substantial loss of midbrain dopamine (mDA) neurons in the substantia nigra pars compacta and to decreased innervation to the striatum. Although existing drug therapy available can relieve the...
Main Authors: | Mengmeng Wang, King-Hwa Ling, Jun Jie Tan, Cheng-Biao Lu |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2020-06-01
|
Series: | Cells |
Subjects: | |
Online Access: | https://www.mdpi.com/2073-4409/9/6/1489 |
Similar Items
-
Cryopreservation of Human Midbrain Dopaminergic Neural Progenitor Cells Poised for Neuronal Differentiation
by: Nicola J. Drummond, et al.
Published: (2020-11-01) -
Efficient expansion and dopaminergic differentiation of human fetal ventral midbrain neural stem cells by midbrain morphogens
by: Diogo Ribeiro, et al.
Published: (2013-01-01) -
Differentiation and Characterization of Dopaminergic Neurons From Baboon Induced Pluripotent Stem Cells
by: Douglas A. Grow, et al.
Published: (2016-09-01) -
Electrophysiological Quality Control of Human Dopaminergic Neurons: Are We Doing Enough?
by: Vincent Seutin
Published: (2021-08-01) -
Direct conversion of human fibroblasts into dopaminergic neuron-like cells using small molecules and protein factors
by: Hua Qin, et al.
Published: (2020-11-01)